PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

<p><span style="font-weight: 400;">In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palatable) psychedelic compounds.</span></p> <p><span style= "font-weight: 400;">www.psychedelicstoday.com</span></p>